RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS) will report financial results for the first quarter ended March 31 on Wednesday, May 6, after market close.
The company will host a conference call at 4:30 p.m. Eastern Time to discuss the results.
Participants can join the call domestically at 1-877-704-4453 or internationally at 1-201-389-0920 using conference ID 13759844. A live webcast will be available at https://viavid.webcasts.com/starthere.jsp?ei=1758980&tp_key=c6e146a2dc and on the investor relations section of the company’s website at https://ir.mineralystx.com/news-events.
Mineralys develops therapies targeting hypertension and related conditions, including chronic kidney disease and obstructive sleep apnea, with a focus on disorders linked to aldosterone. Its lead product candidate, lorundrostat, is an oral aldosterone synthase inhibitor.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.